by Jen Hodson | Dec 3, 2018 | Press Releases |
Topics to include DNA and RNA profiling and next-generation sequencing of tumors San Antonio, TX – Dec 3, 2018 – Significant developments in breast cancer research will be presented by NantHealth (NASDAQ: NH) at the San Antonio Breast Cancer Symposium this week....
by Jen Hodson | Nov 15, 2018 | Press Releases |
Total Revenue in Q3 was $22.3 Million SaaS revenue of $15.9 million in Q3, up 5% from $15.2 million in prior year Q3 Enhanced efficiencies continued to drive reduced operating expenses and improved adjusted bottom line results Sequencing and Molecular Analysis, 930...
by Jen Hodson | Nov 7, 2018 | Press Releases |
New DeviceConX Enhancements Showcased at the Healthcare Information and Management Systems Society (HIMSS) Interoperability Showcase™ Asia Pacific Conference and Exhibition Featuring NantHealth, B. Braun Australia, GE Healthcare, and iProcedures BRISBANE, AUSTRALIA...
by Jen Hodson | Nov 6, 2018 | Events, Press Releases |
–Slight Delay in Reporting Financial Results, Due to Effects of Hurricane Michael– CULVER CITY, Calif. – (November 6, 2018) — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will...
by Jen Hodson | Oct 29, 2018 | Press Releases |
NantHealth’s Liquid GPS™ technology shows promise in the monitoring of key biomarkers in metastatic colorectal cancer MUNICH and CULVER CITY, CA – (October 29, 2018) — Significant developments in cancer research were presented by NantHealth (NASDAQ: NH)...
